152 related articles for article (PubMed ID: 9167178)
1. Prognostic significance of nm23 protein expression in malignant melanoma. An immunohistochemical study.
van den Oord JJ; Maes A; Stas M; Nuyts J; De Wever I; De Wolf-Peeters C
Melanoma Res; 1997 Apr; 7(2):121-8. PubMed ID: 9167178
[TBL] [Abstract][Full Text] [Related]
2. Expression of NM23 protein in acquired melanocytic nevi, malignant melanoma and metastases of malignant melanoma: an immunohistological assessment in human skin.
Reichrath J; Seyfried P; Braun R; Müller SM; Baum HP; Bahmer FA
Dermatology; 1997; 194(2):136-9. PubMed ID: 9094461
[TBL] [Abstract][Full Text] [Related]
3. The role of nm23 in melanoma progression and its prognostic significance.
Betke H; Korabiowska M; Brinck U; Trybus-Gałuszka H; Kellner S; Okoń K; Stachura J; Droese M
Pol J Pathol; 1998; 49(2):93-6. PubMed ID: 9798412
[TBL] [Abstract][Full Text] [Related]
4. An immunohistochemical analysis of nm23 gene product expression in uveal melanoma.
Greco IM; Calvisi G; Ventura L; Cerrito F
Melanoma Res; 1997 Jun; 7(3):231-6. PubMed ID: 9195562
[TBL] [Abstract][Full Text] [Related]
5. Nm23/nucleoside diphosphate (NDP) kinase expression in human malignant melanomas: significance and implications in tumor biology.
Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
Anticancer Res; 1997; 17(1A):505-11. PubMed ID: 9066703
[TBL] [Abstract][Full Text] [Related]
6. Expression of the nm23 metastasis-suppressor gene product in skin tumors.
Kanitakis J; Euvrard S; Bourchany D; Faure M; Claudy A
J Cutan Pathol; 1997 Mar; 24(3):151-6. PubMed ID: 9085150
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of nm23 H-1 protein in conjunctival melanoma and potential precursor lesions.
Seregard S; Oskarsson M; Spângberg B
Exp Eye Res; 1999 Dec; 69(6):671-6. PubMed ID: 10620396
[TBL] [Abstract][Full Text] [Related]
8. Expression of metastasis suppressor gene product, nm23 protein, is not inversely correlated with the tumour progression in human malignant melanomas.
Saitoh K; Takahashi H; Yamamoto M; Kishi H; Parsons PG
Histopathology; 1996 Dec; 29(6):497-505. PubMed ID: 8971556
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical demonstration of the nm23-H1 gene product in human malignant melanoma and Spitz nevi.
Lee CS; Pirdas A; Lee MW
Pathology; 1996 Aug; 28(3):220-4. PubMed ID: 8912348
[TBL] [Abstract][Full Text] [Related]
10. The value of Nm23 expression as an independent prognostic indicator in primary thick melanoma.
Holmes SC; MacKie RM
J Cutan Pathol; 1996 Aug; 23(4):344-9. PubMed ID: 8864922
[TBL] [Abstract][Full Text] [Related]
11. Expression of NM23 in human melanoma progression and metastasis.
Easty DJ; Maung K; Lascu I; Véron M; Fallowfield ME; Hart IR; Bennett DC
Br J Cancer; 1996 Jul; 74(1):109-14. PubMed ID: 8679442
[TBL] [Abstract][Full Text] [Related]
12. A low NM23.H1 gene expression identifying high malignancy human melanomas.
Caligo MA; Grammatico P; Cipollini G; Varesco L; Del Porto G; Bevilacqua G
Melanoma Res; 1994 Jun; 4(3):179-84. PubMed ID: 7919963
[TBL] [Abstract][Full Text] [Related]
13. nm23 as a prognostic marker in primary cutaneous melanoma: evaluation using tissue microarray in a patient group with long-term follow-up.
Pacifico MD; Grover R; Richman PI; Buffa F; Daley FM; Wilson GD
Melanoma Res; 2005 Oct; 15(5):435-40. PubMed ID: 16179871
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of nm23 in primary invasive malignant melanoma is predictive of survival outcome.
McDermott NC; Milburn C; Curran B; Kay EW; Barry Walsh C; Leader MB
J Pathol; 2000 Feb; 190(2):157-62. PubMed ID: 10657013
[TBL] [Abstract][Full Text] [Related]
15. NM23 expression in metastasis of malignant melanoma is a predictive prognostic parameter correlated with survival.
Xerri L; Grob JJ; Battyani Z; Gouvernet J; Hassoun J; Bonerandi JJ
Br J Cancer; 1994 Dec; 70(6):1224-8. PubMed ID: 7981081
[TBL] [Abstract][Full Text] [Related]
16. The loss of NM23 protein in malignant melanoma predicts lymphatic spread without affecting survival.
Döme B; Somlai B; Tímár J
Anticancer Res; 2000; 20(5C):3971-4. PubMed ID: 11268486
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic expression of nm23 predicts the potential for cerebral metastasis in patients with primary cutaneous melanoma.
Sarris M; Scolyer RA; Konopka M; Thompson JF; Harper CG; Lee CS
Melanoma Res; 2004 Feb; 14(1):23-7. PubMed ID: 15091190
[TBL] [Abstract][Full Text] [Related]
18. Dermatopathological indicators of poor melanoma prognosis are significantly inversely correlated with the expression of NM23 protein in primary cutaneous melanoma.
Ferrari D; Lombardi M; Ricci R; Michiara M; Santini M; De Panfilis G
J Cutan Pathol; 2007 Sep; 34(9):705-12. PubMed ID: 17696918
[TBL] [Abstract][Full Text] [Related]
19. Automated and quantitative immunocytochemical assays of Nm23/NDPK protein in breast carcinomas.
Charpin C; Bouvier C; Garcia S; Martini F; Andrac L; Lavaut MN; Allasia C
Int J Cancer; 1997 Aug; 74(4):416-20. PubMed ID: 9291431
[TBL] [Abstract][Full Text] [Related]
20. nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma.
Zafon C; Obiols G; Castellví J; Tallada N; Galofré P; Gemar E; Mesa J; Simó R
J Clin Endocrinol Metab; 2001 Aug; 86(8):3975-80. PubMed ID: 11502841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
